Artificial Neural Network-Derived Cerebral Metabolic Rate of Oxygen for Differentiating Glioblastoma and Brain Metastasis in MRI: A Feasibility Study

Glioblastoma may appear similar to cerebral metastasis on conventional MRI in some cases, but their therapies differ significantly. This prospective feasibility study was aimed at differentiating them by applying the quantitative susceptibility mapping and quantitative blood-oxygen-level-dependent (...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hakim Baazaoui, Simon Hubertus, Máté E. Maros, Sherif A. Mohamed, Alex Förster, Lothar R. Schad, Holger Wenz
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
T
Acceso en línea:https://doaj.org/article/4b5856c301b04c5784719615773daec1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4b5856c301b04c5784719615773daec1
record_format dspace
spelling oai:doaj.org-article:4b5856c301b04c5784719615773daec12021-11-11T15:01:28ZArtificial Neural Network-Derived Cerebral Metabolic Rate of Oxygen for Differentiating Glioblastoma and Brain Metastasis in MRI: A Feasibility Study10.3390/app112199282076-3417https://doaj.org/article/4b5856c301b04c5784719615773daec12021-10-01T00:00:00Zhttps://www.mdpi.com/2076-3417/11/21/9928https://doaj.org/toc/2076-3417Glioblastoma may appear similar to cerebral metastasis on conventional MRI in some cases, but their therapies differ significantly. This prospective feasibility study was aimed at differentiating them by applying the quantitative susceptibility mapping and quantitative blood-oxygen-level-dependent (QSM + qBOLD) model to these entities for the first time. We prospectively included 15 untreated patients with glioblastoma (n = 7, median age: 68 years, range: 54–84 years) or brain metastasis (n = 8, median age 66 years, range: 50–78 years) who underwent preoperative MRI including multi-gradient echo and arterial spin labeling sequences. Oxygen extraction fraction (OEF), cerebral blood flow (CBF) and cerebral metabolic rate of oxygen (CMRO<sub>2</sub>) were calculated in the contrast-enhancing tumor (CET) and peritumoral non-enhancing T2 hyperintense region (NET2), using an artificial neural network. We demonstrated that OEF in CET was significantly lower (<i>p</i> = 0.03) for glioblastomas than metastases, all features were significantly higher (<i>p</i> = 0.01) in CET than in NET2 for metastasis patients only, and the ratios of CET/NET2 for CBF (<i>p</i> = 0.04) and CMRO<sub>2</sub> (<i>p</i> = 0.01) were significantly higher in metastasis patients than in glioblastoma patients. Discriminative power of a support-vector machine classifier was highest with a combination of two features, yielding an area under the receiver operating characteristic curve of 0.94 with 93% diagnostic accuracy. QSM + qBOLD allows for robust differentiation of glioblastoma and cerebral metastasis while yielding insights into tumor oxygenation.Hakim BaazaouiSimon HubertusMáté E. MarosSherif A. MohamedAlex FörsterLothar R. SchadHolger WenzMDPI AGarticlebrain metastasisglioblastomamachine learningoxygenationtumor infiltrationTechnologyTEngineering (General). Civil engineering (General)TA1-2040Biology (General)QH301-705.5PhysicsQC1-999ChemistryQD1-999ENApplied Sciences, Vol 11, Iss 9928, p 9928 (2021)
institution DOAJ
collection DOAJ
language EN
topic brain metastasis
glioblastoma
machine learning
oxygenation
tumor infiltration
Technology
T
Engineering (General). Civil engineering (General)
TA1-2040
Biology (General)
QH301-705.5
Physics
QC1-999
Chemistry
QD1-999
spellingShingle brain metastasis
glioblastoma
machine learning
oxygenation
tumor infiltration
Technology
T
Engineering (General). Civil engineering (General)
TA1-2040
Biology (General)
QH301-705.5
Physics
QC1-999
Chemistry
QD1-999
Hakim Baazaoui
Simon Hubertus
Máté E. Maros
Sherif A. Mohamed
Alex Förster
Lothar R. Schad
Holger Wenz
Artificial Neural Network-Derived Cerebral Metabolic Rate of Oxygen for Differentiating Glioblastoma and Brain Metastasis in MRI: A Feasibility Study
description Glioblastoma may appear similar to cerebral metastasis on conventional MRI in some cases, but their therapies differ significantly. This prospective feasibility study was aimed at differentiating them by applying the quantitative susceptibility mapping and quantitative blood-oxygen-level-dependent (QSM + qBOLD) model to these entities for the first time. We prospectively included 15 untreated patients with glioblastoma (n = 7, median age: 68 years, range: 54–84 years) or brain metastasis (n = 8, median age 66 years, range: 50–78 years) who underwent preoperative MRI including multi-gradient echo and arterial spin labeling sequences. Oxygen extraction fraction (OEF), cerebral blood flow (CBF) and cerebral metabolic rate of oxygen (CMRO<sub>2</sub>) were calculated in the contrast-enhancing tumor (CET) and peritumoral non-enhancing T2 hyperintense region (NET2), using an artificial neural network. We demonstrated that OEF in CET was significantly lower (<i>p</i> = 0.03) for glioblastomas than metastases, all features were significantly higher (<i>p</i> = 0.01) in CET than in NET2 for metastasis patients only, and the ratios of CET/NET2 for CBF (<i>p</i> = 0.04) and CMRO<sub>2</sub> (<i>p</i> = 0.01) were significantly higher in metastasis patients than in glioblastoma patients. Discriminative power of a support-vector machine classifier was highest with a combination of two features, yielding an area under the receiver operating characteristic curve of 0.94 with 93% diagnostic accuracy. QSM + qBOLD allows for robust differentiation of glioblastoma and cerebral metastasis while yielding insights into tumor oxygenation.
format article
author Hakim Baazaoui
Simon Hubertus
Máté E. Maros
Sherif A. Mohamed
Alex Förster
Lothar R. Schad
Holger Wenz
author_facet Hakim Baazaoui
Simon Hubertus
Máté E. Maros
Sherif A. Mohamed
Alex Förster
Lothar R. Schad
Holger Wenz
author_sort Hakim Baazaoui
title Artificial Neural Network-Derived Cerebral Metabolic Rate of Oxygen for Differentiating Glioblastoma and Brain Metastasis in MRI: A Feasibility Study
title_short Artificial Neural Network-Derived Cerebral Metabolic Rate of Oxygen for Differentiating Glioblastoma and Brain Metastasis in MRI: A Feasibility Study
title_full Artificial Neural Network-Derived Cerebral Metabolic Rate of Oxygen for Differentiating Glioblastoma and Brain Metastasis in MRI: A Feasibility Study
title_fullStr Artificial Neural Network-Derived Cerebral Metabolic Rate of Oxygen for Differentiating Glioblastoma and Brain Metastasis in MRI: A Feasibility Study
title_full_unstemmed Artificial Neural Network-Derived Cerebral Metabolic Rate of Oxygen for Differentiating Glioblastoma and Brain Metastasis in MRI: A Feasibility Study
title_sort artificial neural network-derived cerebral metabolic rate of oxygen for differentiating glioblastoma and brain metastasis in mri: a feasibility study
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/4b5856c301b04c5784719615773daec1
work_keys_str_mv AT hakimbaazaoui artificialneuralnetworkderivedcerebralmetabolicrateofoxygenfordifferentiatingglioblastomaandbrainmetastasisinmriafeasibilitystudy
AT simonhubertus artificialneuralnetworkderivedcerebralmetabolicrateofoxygenfordifferentiatingglioblastomaandbrainmetastasisinmriafeasibilitystudy
AT mateemaros artificialneuralnetworkderivedcerebralmetabolicrateofoxygenfordifferentiatingglioblastomaandbrainmetastasisinmriafeasibilitystudy
AT sherifamohamed artificialneuralnetworkderivedcerebralmetabolicrateofoxygenfordifferentiatingglioblastomaandbrainmetastasisinmriafeasibilitystudy
AT alexforster artificialneuralnetworkderivedcerebralmetabolicrateofoxygenfordifferentiatingglioblastomaandbrainmetastasisinmriafeasibilitystudy
AT lotharrschad artificialneuralnetworkderivedcerebralmetabolicrateofoxygenfordifferentiatingglioblastomaandbrainmetastasisinmriafeasibilitystudy
AT holgerwenz artificialneuralnetworkderivedcerebralmetabolicrateofoxygenfordifferentiatingglioblastomaandbrainmetastasisinmriafeasibilitystudy
_version_ 1718437598496555008